Iovance Biotherapeutics, Inc.

NasdaqGM:IOVA

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

Location

United States

Market Cap

USD 891.60 M

Share Price

USD 2.67

Avg Daily Volume

18,593,591

Change (1 day)

-8.56%

Change (1 year)

-70.20%

Change (YTD)

-63.92%

Iovance Biotherapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD -334.39 M

Iovance Biotherapeutics, Inc. Operating Cash Flow is USD -334.39 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -12.98% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Iovance Biotherapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD -384.28 M, a 20.55% change year over year.
Iovance Biotherapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD -318.77 M, a 33.18% change year over year.
Iovance Biotherapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD -239.35 M, a 18.35% change year over year.
Iovance Biotherapeutics, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -202.23 M, a 3.66% change year over year.